|
Description:
|
|
A series of expert interviews conducted at EASD 2019. This includes:
- Professor Steve Bain, discussing the PIONEER trials of oral semaglutide
- Professor Dr Thomas Danne, discussing approaches to type 1 diabetes management
- Professor Jens Juul Holst, discussing gastric peptides as actionable targets
- Professor Didac Maruicio, discussing the CONCLUDE trial
This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education. |